Amal El-Mabhouh has not added Biography.
If you are Amal El-Mabhouh and would like to personalize this page please email our Author Liaison for assistance.
Preclinical investigations of drug and radionuclide conjugates of bisphosphonates for the treatment of metastatic bone cancer.
Cancer biotherapy & radiopharmaceuticals Oct, 2004 | Pubmed ID: 15650456
188Re-labeled bisphosphonates as potential bifunctional agents for therapy in patients with bone metastases.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine Apr, 2005 | Pubmed ID: 15701408
A 99mTc-labeled gemcitabine bisphosphonate drug conjugate as a probe to assess the potential for targeted chemotherapy of metastatic bone cancer.
Nuclear medicine and biology Aug, 2006 | Pubmed ID: 16934690
188Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases.
European journal of nuclear medicine and molecular imaging Jul, 2008 | Pubmed ID: 18265977
Evaluation of bendamustine in combination with fludarabine in primary chronic lymphocytic leukemia cells.
Blood Jun, 2014 | Pubmed ID: 24747434
Millipore Sigma
Gloria Figueroa1,
Tiyash Parira1,
Alejandra Laverde1,
Gianna Casteleiro1,
Amal El-Mabhouh2,
Madhavan Nair1,
Marisela Agudelo1
1Department of Immunology, Herbert Wertheim College of Medicine, Florida International University,
2, Millipore Sigma
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
Research
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
Education
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
Authors
Librarians
Access
ABOUT JoVE
JoVE Sitemap
Copyright © 2025 MyJoVE Corporation. All rights reserved
We use cookies to enhance your experience on our website.
By continuing to use our website or clicking “Continue”, you are agreeing to accept our cookies.
Learn More